FIELD: chemistry.
SUBSTANCE: group of inventions relates to field of biotechnology. Method of selecting food diet includes determination of food diet or substance, which increase amount of microRNA, present in mammalian milk, applying correlation of miroRNA profiles in milk and food diet, obtained by mammal, or substance, contained in food diet, as index. Profiles of microRNA in milk, identified before and after dietary intake, are compared, and if amount of at least one type of microRNA, identified after intake, is higher than that identified before intake, it is supposed that diet increased amount of microRNA in milk. Method additionally includes measurement of microRNA in milk and microRNA profiles in serum of plasma, and if amount of microRNA, contained both in milk and serum or plasma, after dietary intake increases in milk by 1.47 times or higher in comparison with that identified in serum or plasma, it is supposed that diet increases amount of microRNA in milk.
EFFECT: application of invention group makes it possible to obtain breast milk, possessing immunostimulating action.
6 cl, 7 dwg, 11 tbl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
SET OF OLIGODEOXYRIBONUCLEOTIDE PRIMERS FOR DIAGNOSING CARDIOVASCULAR DISEASES AND DETECTING RISK OF THEIR DEVELOPMENT BASED ON BIOMOLECULAR MARKER microRNA hsa-miR-143-5p BY QUANTITATIVE PCR AND USE THEREOF | 2025 |
|
RU2838258C1 |
SET OF OLIGODEOXYRIBONUCLEOTIDE PRIMERS FOR DIAGNOSING CARDIOVASCULAR DISEASES AND DETECTING RISK OF THEIR DEVELOPMENT BASED ON BIOMOLECULAR MARKER microRNA hsa-miR-143-3p BY QUANTITATIVE PCR AND USE THEREOF | 2025 |
|
RU2838257C1 |
SET OF OLIGODEOXYRIBONUCLEOTIDE PRIMERS FOR DIAGNOSING CARDIOVASCULAR DISEASES AND DETECTING RISK OF THEIR DEVELOPMENT BASED ON BIOMOLECULAR MARKER microRNA hsa-miR-145-3p BY QUANTITATIVE PCR AND USE THEREOF | 2025 |
|
RU2838260C1 |
RECOMBINANT PLASMID DNA CODING microRNA hsa-miR-145-5p, AND ITS USE AS POSITIVE CONTROL IN REAL-TIME PCR FOR DIAGNOSING CARDIOVASCULAR DISEASES AND DETECTING RISK OF THEIR DEVELOPMENT | 2025 |
|
RU2837874C1 |
RECOMBINANT PLASMID DNA CODING microRNA hsa-miR-143-5p, AND ITS USE AS POSITIVE CONTROL IN REAL-TIME PCR FOR DIAGNOSING CARDIOVASCULAR DISEASES AND DETECTING RISK OF THEIR DEVELOPMENT | 2025 |
|
RU2837872C1 |
MICRORNA-124 AS BIOMARKER | 2014 |
|
RU2687366C2 |
VERSIONS OF RECOMBINANT AAV AND USE THEREOF | 2015 |
|
RU2738421C2 |
PHARMACEUTICAL COMPOSITIONS, KITS AND METHODS OF TREATING TUMORS | 2019 |
|
RU2810906C2 |
METHOD FOR PRODUCING HIGH-FUNCTION THROMBOCYTES | 2016 |
|
RU2724533C2 |
DRUG FOR TREATMENT OF TISSUE FIBROSIS BASED ON COMPONENTS OF SECRETOME OF MESENCHYMAL STROMAL CELLS, METHOD FOR OBTAINING AND APPLYING REMEDY | 2020 |
|
RU2766707C1 |
Authors
Dates
2015-03-27—Published
2010-07-14—Filed